retatrutide phase 2 trial obesity nejm 2023 Michael Weintraub, MD on X: "Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released results demonstrating 25% weight loss in half of people with #obesity. This amount of weight retatrutide phase 2 results obesity
Pay in 4 interest-free payments of $5.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28




















![Karlov of the Ghost Council (Anime Borderless) [Ravnica Remastered] H9](https://cdn.shopify.com/s/files/1/0745/9002/8087/products/8c3db675-10ad-5ef0-9025-e994548415d0_38fbd4cc-839f-4267-9b25-5b077271c9b4.png?v=1706911764)
